Physician profile
Daniel Slaughter
NPI 1477527778
$17,547.15
in general payments reported to CMS, 2019-2025
21 companies · $410 in 2025
The $410 reported for 2025 was more than what 75% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,193 · 2020: $811 · 2021: $11K · 2022: $508 · 2023: $698 · 2024: $211 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,318.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intersect Ent, INC. | $10,625.33 | 2021-2022 | |
| Stryker Corporation | $4,497.92 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $465.18 | 2019-2025 | Dupixent |
| Inspire Medical Systems, INC. | $418.74 | 2023-2025 | Inspire |
| Medtronic, INC. | $254.47 | 2021-2022 | |
| Glaxosmithkline, LLC. | $236.11 | 2021-2025 | Nucala |
| Acclarent, INC | $205.77 | 2020-2022 | |
| Genzyme Corporation | $187.68 | 2021-2025 | |
| Kaleo, INC. | $145.41 | 2019-2020 | |
| Horizon Therapeutics Plc | $114.62 | 2019-2020 | |
| Aerin Medical INC. | $86.07 | 2023-2025 | |
| Biosense Webster, INC. | $84.08 | 2022 | |
| Celgene Corporation | $44.60 | 2023 | Pomalyst |
| Integra Lifesciences Corporation | $41.61 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Medtronic USA, INC. | $40.40 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $29.71 | 2024 | Ryaltris |
| Resmed Corp | $16.67 | 2023 | |
| Jazz Pharmaceuticals INC. | $14.19 | 2021 | |
| Greer Laboratories, INC. | $13.64 | 2019 | |
| Olympus America INC. | $13.25 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $11.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Slaughter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.